Literature DB >> 62281

Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.

P H Lange, K R McIntire, T A Waldmann, T R Hakala, E E Fraley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 62281     DOI： 10.1056/NEJM197611252952207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  The differential diagnosis of testicular germ cell tumors in theory and practice. A critical analysis of two major systems of classifiction and review of 389 cases.

Authors:  A R von Hochstetter; C E Hedinger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982-08

2.  Rates of death from testicular cancer in Ontario in 1964-82: analysis by major histologic subgroups.

Authors:  L D Marrett; H K Weir; E A Clarke; C J Magee
Journal:  CMAJ       Date:  1986-11-01       Impact factor: 8.262

3.  An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.

Authors:  M R Williams; A Turkes; D Pearson; K Griffiths; R W Blamey
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

4.  The use of serum tumor markers in the management of patients with malignancy.

Authors:  M Markman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 5.  Response of paraneoplastic syndromes to antineoplastic therapy.

Authors:  M Markman
Journal:  West J Med       Date:  1986-05

6.  Value correlation of alpha-fetoprotein and human chorionic gonadotropin with the results of lymphadenectomy in non-seminomatous testicular tumours.

Authors:  J Kausitz; S Hupka; D Ondrus; J Michalko
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

7.  Tumour antigens associated with primary mediastinal choriocarcinoma.

Authors:  J C Forest; J Talbot; M Pagé; J M Loiselle
Journal:  Can Med Assoc J       Date:  1977-12-17       Impact factor: 8.262

8.  Serum alpha-fetoprotein levels in human disease: perspective from a highly specific monoclonal radioimmunoassay.

Authors:  D H Bellet; J R Wands; K J Isselbacher; C Bohuon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Chemotherapy of advanced malignant teratomas.

Authors:  E S Newlands; R H Begent; S B Kaye; G J Rustin; K D Bagshawe
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

10.  Brain metastases in malignant teratoma: a review of four years' experience and an assessment of the role of tumour markers.

Authors:  S B Kaye; K D Bagshawe; T J McElwain; M J Peckham
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.